GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (XCNQ:SNN) » Definitions » 5-Year EBITDA Growth Rate

Sunniva (XCNQ:SNN) 5-Year EBITDA Growth Rate : 0.00% (As of Sep. 2019)


View and export this data going back to 2018. Start your Free Trial

What is Sunniva 5-Year EBITDA Growth Rate?

Sunniva's EBITDA per Share for the three months ended in Sep. 2019 was C$-0.14.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Sunniva's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Sunniva's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunniva's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunniva's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sunniva's 5-Year EBITDA Growth Rate falls into.



Sunniva 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Sunniva  (XCNQ:SNN) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Sunniva 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sunniva's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunniva (XCNQ:SNN) Business Description

Traded in Other Exchanges
N/A
Address
200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2
Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.
Executives
Mark Hamish Kimmins Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)

Sunniva (XCNQ:SNN) Headlines

From GuruFocus

Smith & Nephew: A Medical Equipment Opportunity

By The City Letter 08-09-2022

Smith & Nephew Is Reverting to Fair Value

By Praveen Chawla 01-25-2023